Found: 40
Select item for more details and to access through your institution.
The Clinical Use of Interferons in the Management of Neuroendocrine Gastroenteropancreatic Tumors.
- Published in:
- Annals of the New York Academy of Sciences, 1994, v. 733, n. 1, p. 471, doi. 10.1111/j.1749-6632.1994.tb17297.x
- By:
- Publication type:
- Article
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 9, p. 883, doi. 10.1159/000511905
- By:
- Publication type:
- Article
Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 3/4, p. 217, doi. 10.1159/000503833
- By:
- Publication type:
- Article
Unmet Needs in Appendiceal Neuroendocrine Neoplasms.
- Published in:
- Neuroendocrinology, 2019, v. 108, n. 1, p. 37, doi. 10.1159/000493894
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 295, doi. 10.1159/000475526
- By:
- Publication type:
- Article
DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 2, p. 170, doi. 10.1159/000452891
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 245, doi. 10.1159/000461583
- By:
- Publication type:
- Article
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 6, p. 740, doi. 10.3109/0284186X.2010.492791
- By:
- Publication type:
- Article
Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®).
- Published in:
- 2010
- By:
- Publication type:
- Letter
Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 6, p. 741, doi. 10.1080/02841860601048388
- By:
- Publication type:
- Article
Treatment of endocrine pancreatic tumors.
- Published in:
- Acta Oncologica, 2005, v. 44, n. 4, p. 329, doi. 10.1080/02841860510029941
- By:
- Publication type:
- Article
In Vivo Cellular Distribution and Endocytosis of the Somatostatin Receptor-Ligand Complex.
- Published in:
- Acta Oncologica, 1999, v. 38, n. 3, p. 383, doi. 10.1080/028418699431483
- By:
- Publication type:
- Article
Treatment with High Dose [111In-DTPA-D-PHE1]-Octreotide in Patients with Neuroendocrine Tumors: Evaluation of Therapeutic and Toxic Effects.
- Published in:
- Acta Oncologica, 1999, v. 38, n. 3, doi. 10.1080/028418699431465
- By:
- Publication type:
- Article
Somatostatin Receptor Scintigraphy of Carcinoid Tumours Using the [<sup>111</sup>In-Dtpa-D-Phe<sup>1</sup>]-Octreotide.
- Published in:
- Acta Oncologica, 1993, v. 32, n. 7/8, p. 783, doi. 10.3109/02841869309096136
- By:
- Publication type:
- Article
Long-Term Management of the Carcinoid Syndrome Treatment with octreotide alone and in combination with alpha-interferon.
- Published in:
- Acta Oncologica, 1993, v. 32, n. 2, p. 225, doi. 10.3109/02841869309083916
- By:
- Publication type:
- Article
Combined Alpha- and Gamma-Interferon Therapy for Malignant Midgut Carcinoid Tumors a phase I-II trial.
- Published in:
- Acta Oncologica, 1993, v. 32, n. 2, p. 231, doi. 10.3109/02841869309083917
- By:
- Publication type:
- Article
Loss of Y in leukocytes as a risk factor for critical COVID-19 in men.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01144-5
- By:
- Publication type:
- Article
Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer.
- Published in:
- Nature Genetics, 2014, v. 46, n. 6, p. 624, doi. 10.1038/ng.2966
- By:
- Publication type:
- Article
European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 9, p. 1, doi. 10.1111/jne.13423
- By:
- Publication type:
- Article
Prevalence of metastases outside the liver and abdominal lymph nodes on <sup>68</sup>Ga‐DOTATOC‐PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 5, p. 1, doi. 10.1111/jne.13391
- By:
- Publication type:
- Article
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 3, p. 1, doi. 10.1111/jne.13249
- By:
- Publication type:
- Article
Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre.
- Published in:
- Journal of Neuroendocrinology, 2021, v. 33, n. 12, p. 1, doi. 10.1111/jne.13030
- By:
- Publication type:
- Article
Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 913, doi. 10.3390/cancers14040913
- By:
- Publication type:
- Article
PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0243900
- By:
- Publication type:
- Article
High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours.
- Published in:
- European Journal of Endocrinology, 2004, v. 151, n. 1, p. 0107
- By:
- Publication type:
- Article
Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67670-7
- By:
- Publication type:
- Article
Interf erons Alone or in Combination with Chemotherapy or Other Biologicals in the Treatment of Neuroendocrine Gut and Pancreatic Tumors.
- Published in:
- Digestion, 1994, v. 55, n. S3, p. 64, doi. 10.1159/000201204
- By:
- Publication type:
- Article
Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164354
- By:
- Publication type:
- Article
Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2.
- Published in:
- Endocrine (1355008X), 2021, v. 72, n. 3, p. 893, doi. 10.1007/s12020-020-02534-8
- By:
- Publication type:
- Article
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 5, p. 431, doi. 10.1080/0284186X.2023.2212411
- By:
- Publication type:
- Article
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 7, p. 931, doi. 10.1080/0284186X.2021.1921262
- By:
- Publication type:
- Article
Treatment with somatostatin analogues may delay progression of neuroendocrine tumours.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 10, p. 1283, doi. 10.3109/0284186X.2014.966921
- By:
- Publication type:
- Article
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 10, p. 1284, doi. 10.3109/0284186X.2014.941999
- By:
- Publication type:
- Article
Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 56, n. 4, p. 584, doi. 10.1002/pbc.22913
- By:
- Publication type:
- Article
Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma.
- Published in:
- Endocrine Pathology, 2019, v. 30, n. 3, p. 173, doi. 10.1007/s12022-019-09584-3
- By:
- Publication type:
- Article
Octreoscan in patients with bronchial carcinoid tumours.
- Published in:
- Clinical Endocrinology, 2003, v. 59, n. 6, p. 793, doi. 10.1046/j.1365-2265.2003.01931.x
- By:
- Publication type:
- Article
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
- Published in:
- Medical Oncology, 2018, v. 35, n. 4, p. 1, doi. 10.1007/s12032-018-1103-x
- By:
- Publication type:
- Article
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187667
- By:
- Publication type:
- Article
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0176059
- By:
- Publication type:
- Article
Nuclear Localization of <sup>111</sup>In After Intravenous Injection of [<sup>111</sup>In-DTPA-D Phe¹]-Octreotide in Patients with Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 9, p. 1514
- By:
- Publication type:
- Article